サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1422958

Gタンパク質共役受容体（GPCR）市場：製品別、アッセイタイプ別、用途別、地域別、2024-2032年

G-Protein Coupled Receptors Market by Product, Assay Type, Application, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
Gタンパク質共役受容体（GPCR）市場：製品別、アッセイタイプ別、用途別、地域別、2024-2032年
出版日: 2024年01月30日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のGタンパク質共役受容体（GPCR）市場規模は、2023年に34億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて5.69%の成長率（CAGR）を示し、2032年までに57億米ドルに達すると予測しています。創薬におけるGPCRの採用の増加、がん患者数の増加、広範な研究開発（R&D）活動は、市場を牽引する主な要因の一つです。

Gタンパク質共役受容体（GPCR）は、ヒトゲノムにコードされる最大のタンパク質ファミリーです。GPCRは細胞にシグナルを伝達するシグナル伝達分子であり、細胞外からの刺激を細胞内の反応に変換する上で重要な役割を果たしています。GPCRは細胞膜に存在し、あらゆる生理的プロセスに関与しています。GPCRは細胞表面の受容体で、脂質、糖、光エネルギー、ペプチド、タンパク質の形でメッセージの受信箱のような働きをします。これらの受容体は、炎症性疾患、代謝異常、心疾患、がん、単発性疾患など、様々な疾患の治療に広く用いられています。その結果、GPCRは哺乳類、植物、微生物、無脊椎動物を含むいくつかの生物の細胞膜にも存在しています。

Gタンパク質共役受容体（GPCR）の市場動向：

世界中で創薬へのGPCRの採用が増加していることが、市場成長を促進する主な要因の1つです。これに伴い、がん患者数の増加や心血管感染症、呼吸困難などの生活習慣病の増加により、新規医薬品の開発にGPCRが広く利用されていることが、市場の成長を後押ししています。さらに、GPCRは細胞表面に存在するため、さまざまな化学物質や生物学的薬剤によって調節することが可能であり、いくつかの生理的プロセスにおけるGPCRの広範な応用が、もう一つの成長促進要因として作用しています。これとは別に、治療薬の生産能力を向上させるために、自動化と革新的技術を医薬品開発スクリーニング手順と統合することが、市場成長の原動力となっています。さらに、新薬の受容体構造や製剤化を合理化するための計算アプローチの進歩など、効果的な創薬手法の著しい発展が市場成長を後押ししています。さらに、腫瘍学や、浸潤、遊走、血管再形成など、がん生物学のさまざまな側面でGPCRが広く採用されていることも、市場成長に大きな後押しとなっています。このほか、腫瘍の転移や増殖を解読し、効果的な治療法を開発するためのGPCRの利用が増加していることも、市場の成長にプラスの影響を与えています。その他の要因としては、広範な研究開発（R&D）活動、さまざまな自動化の改善、環状アデノシン一リン酸（cAMP）の広範な採用、バイオテクノロジーおよびバイオ医薬品分野における政府のさまざまなイニシアチブの実施などが挙げられ、市場の成長を促進すると予想されています。

本レポートで扱う主な質問

  • 世界のGタンパク質共役受容体（GPCR）市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界のGタンパク質共役受容体（GPCR）市場における市場促進要因、抑制要因、機会は何か？
  • 主要な地域市場とは？
  • 最も魅力的なGタンパク質共役受容体（GPCR）市場はどの国か？
  • 製品別の市場内訳は？
  • アッセイタイプ別の市場内訳は？
  • 用途別の市場内訳は？
  • 世界のGタンパク質共役受容体（GPCR）市場の競争構造は？
  • 世界のGタンパク質共役受容体（GPCR）市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 Gタンパク質共役受容体（GPCR）の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 細胞株
    • 市場動向
    • 市場予測
  • 検出キット
    • 市場動向
    • 市場予測
  • 細胞培養試薬
    • 市場動向
    • 市場予測
  • リガンド
    • 市場動向
    • 市場予測

第7章 市場内訳：アッセイタイプ別

  • cAMP機能アッセイ
    • 市場動向
    • 市場予測
  • カルシウム機能アッセイ
    • 市場動向
    • 市場予測
  • B-アレスチン機能アッセイ
    • 市場動向
    • 市場予測
  • ラジオリガンド結合・GTPγS機能アッセイ
    • 市場動向
    • 市場予測
  • インターナリゼーションアッセイ
    • 市場動向
    • 市場予測
  • トラフィッキングアッセイ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • がん研究
    • 市場動向
    • 市場予測
  • 中枢神経系研究
    • 市場動向
    • 市場予測
  • 代謝研究
    • 市場動向
    • 市場予測
  • 心血管研究
    • 市場動向
    • 市場予測
  • 炎症研究
    • 市場動向
    • 市場予測
  • 呼吸器研究
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abcam plc
    • Becton Dickinson and Company
    • Enzo Biochem Inc.
    • Eurofins DiscoverX Products LLC
    • HD Biosciences Co. Ltd.（WuXi AppTec）
    • Merck KGaA
    • Molecular Devices LLC（Danaher Corporation）
    • PerkinElmer Inc.
    • Promega Corporation
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: G-Protein Coupled Receptors Market: Major Drivers and Challenges
  • Figure 2: Global: G-Protein Coupled Receptors Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: G-Protein Coupled Receptors Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: G-Protein Coupled Receptors Market: Breakup by Product (in %), 2023
  • Figure 5: Global: G-Protein Coupled Receptors Market: Breakup by Assay Type (in %), 2023
  • Figure 6: Global: G-Protein Coupled Receptors Market: Breakup by Application (in %), 2023
  • Figure 7: Global: G-Protein Coupled Receptors Market: Breakup by Region (in %), 2023
  • Figure 8: Global: G-Protein Coupled Receptors (Cell Lines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: G-Protein Coupled Receptors (Cell Lines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: G-Protein Coupled Receptors (Detection Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: G-Protein Coupled Receptors (Detection Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: G-Protein Coupled Receptors (Cell Culture Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: G-Protein Coupled Receptors (Cell Culture Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: G-Protein Coupled Receptors (Ligands) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: G-Protein Coupled Receptors (Ligands) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: G-Protein Coupled Receptors (cAMP Functional Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: G-Protein Coupled Receptors (cAMP Functional Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: G-Protein Coupled Receptors (Calcium Functional Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: G-Protein Coupled Receptors (Calcium Functional Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: G-Protein Coupled Receptors (B-Arrestin Functional Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: G-Protein Coupled Receptors (B-Arrestin Functional Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: G-Protein Coupled Receptors (Radioligand Binding and GTPγS Functional Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: G-Protein Coupled Receptors (Radioligand Binding and GTPγS Functional Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: G-Protein Coupled Receptors (Internalization Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: G-Protein Coupled Receptors (Internalization Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: G-Protein Coupled Receptors (Trafficking Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: G-Protein Coupled Receptors (Trafficking Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: G-Protein Coupled Receptors (Other Assay Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: G-Protein Coupled Receptors (Other Assay Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: G-Protein Coupled Receptors (Cancer Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: G-Protein Coupled Receptors (Cancer Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: G-Protein Coupled Receptors (CNS Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: G-Protein Coupled Receptors (CNS Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: G-Protein Coupled Receptors (Metabolic Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: G-Protein Coupled Receptors (Metabolic Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: G-Protein Coupled Receptors (Cardiovascular Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: G-Protein Coupled Receptors (Cardiovascular Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: G-Protein Coupled Receptors (Inflammation Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: G-Protein Coupled Receptors (Inflammation Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: G-Protein Coupled Receptors (Respiratory Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: G-Protein Coupled Receptors (Respiratory Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: G-Protein Coupled Receptors (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: G-Protein Coupled Receptors (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: North America: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: North America: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: United States: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: United States: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Canada: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Canada: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Asia-Pacific: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Asia-Pacific: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: China: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: China: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Japan: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Japan: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: India: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: India: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: South Korea: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: South Korea: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Australia: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Australia: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Indonesia: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Indonesia: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Europe: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Europe: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Germany: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Germany: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: France: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: France: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: United Kingdom: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: United Kingdom: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Italy: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Italy: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Spain: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Spain: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Russia: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Russia: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Latin America: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Latin America: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Brazil: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Brazil: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Mexico: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Mexico: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Middle East and Africa: G-Protein Coupled Receptors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Middle East and Africa: G-Protein Coupled Receptors Market: Breakup by Country (in %), 2023
  • Figure 92: Middle East and Africa: G-Protein Coupled Receptors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Global: G-Protein Coupled Receptors Industry: Drivers, Restraints, and Opportunities
  • Figure 94: Global: G-Protein Coupled Receptors Industry: Value Chain Analysis
  • Figure 95: Global: G-Protein Coupled Receptors Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: G-Protein Coupled Receptors Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: G-Protein Coupled Receptors Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: G-Protein Coupled Receptors Market Forecast: Breakup by Assay Type (in Million US$), 2024-2032
  • Table 4: Global: G-Protein Coupled Receptors Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: G-Protein Coupled Receptors Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: G-Protein Coupled Receptors Market: Competitive Structure
  • Table 7: Global: G-Protein Coupled Receptors Market: Key Players
目次
Product Code: SR112024A6938

Abstract

The global G-protein coupled receptors (GPCRs) market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.69% during 2024-2032. The increasing adoption of GPCRs in drug discovery, the rising number of cancer cases, and extensive research and development (R&D) activities represent some of the key factors driving the market.

G-protein-coupled receptors (GPCRs) are the largest protein family encoded by the human genome. They are signal-transducing molecules that transmit signals to cells and play a key role in converting an extracellular stimulus into intracellular responses. They are located in the cell membrane and are responsible for all physiological processes. GPCRs are cell surface receptors that act like an inbox for messages in the form of lipids, sugars, light energy, peptides, and proteins. These receptors are widely used in the treatment of various diseases, such as inflammatory disorders, metabolic imbalances, cardiac disorders, cancer, and monogenic disorders. As a result, GPCRs are also found in the cell membranes of several organisms, including mammals, plants, microorganisms, and invertebrates.

G-Protein Coupled Receptors (GPCRs) Market Trends:

The increasing adoption of GPCRs in drug discovery across the globe is one of the key factors driving the market growth. In line with this, the widespread utilization of GPCRs in the development of novel pharmaceuticals due to the rising number of cancer cases and lifestyle-related diseases, such as cardiovascular infections and respiratory difficulties, are favoring the market growth. Moreover, the extensive application of GPCRs in several physiological processes as they can be modulated by a wide range of chemical or biological agents due to their cell-surface location is acting as another growth-inducing factor. Apart from this, the integration of automation and innovative technologies with drug development screening procedures to improve their capabilities in therapeutic production is providing an impetus to the market growth. Furthermore, significant developments in effective drug discovery methods, such as advancements in the computational approaches to streamline receptor structure and formulation of new drugs, are propelling the market growth. Additionally, the widespread adoption of GPCRs in oncology and various aspects of cancer biology, such as invasion, migration, and vascular remolding, is providing a considerable boost to the market growth. Besides this, the increasing utilization of GPCRs for decoding metastasis and growth of tumors and developing effective lines of treatment is positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, various automation improvements, the widespread adoption of cyclic Adenosine Monophosphate (cAMP), and the implementation of various government initiatives in the biotechnology and biopharmaceutical sector are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global G-protein coupled receptors (GPCRs) market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, assay type, and application.

Product Insights:

Cell Lines

Detection Kits

Cell Culture Reagents

Ligands

The report has provided a detailed breakup and analysis of the G-protein coupled receptors (GPCRs) market based on the product. This includes cell lines, detection kits, cell culture reagents and ligands. According to the report, cell lines represented the largest segment.

Assay Type Insights:

cAMP Functional Assays

Calcium Functional Assays

B-Arrestin Functional Assays

Radioligand Binding and GTPγS Functional Assays

Internalization Assays

Trafficking Assays

Others

The report has provided a detailed breakup and analysis of the G-protein coupled receptors (GPCRs) market based on the assay type. This includes cAMP functional, calcium functional, B-Arrestin functional, radioligand binding and GTPγS functional, internalization, and trafficking assays. According to the report, cAMP functional assays represented the largest segment.

Application Insights:

Cancer Research

CNS Research

Metabolic Research

Cardiovascular Research

Inflammation Research

Respiratory Research

Others

The report has provided a detailed breakup and analysis of the G-protein coupled receptors (GPCRs) market based on the application. This includes cancer, CNS, metabolic, cardiovascular, inflammation, respiratory research, and others. According to the report, cancer research represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for G-protein coupled receptors (GPCRs). Some of the factors driving the North America G-protein coupled receptors (GPCRs) market included rising number of cancer cases, extensive research and development (R&D) activities, and various automation improvements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global G-protein coupled receptors (GPCRs) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abcam plc, Becton Dickinson and Company, Enzo Biochem Inc., Eurofins DiscoverX Products LLC, HD Biosciences Co. Ltd. (WuXi AppTec), Merck KGaA, Molecular Devices LLC (Danaher Corporation), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global G-protein coupled receptors (GPCRs) market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global G-protein coupled receptors (GPCRs) market?
  • What are the key regional markets?
  • Which countries represent the most attractive G-protein coupled receptors (GPCRs) markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the assay type?
  • What is the breakup of the market based on the application?
  • What is the competitive structure of the global G-protein coupled receptors (GPCRs) market?
  • Who are the key players/companies in the global G-protein coupled receptors (GPCRs) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global G-Protein Coupled Receptors (GPCRs) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cell Lines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Detection Kits
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cell Culture Reagents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Ligands
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Assay Type

  • 7.1 cAMP Functional Assays
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Calcium Functional Assays
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 B-Arrestin Functional Assays
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Radioligand Binding and GTPγS Functional Assays
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Internalization Assays
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Trafficking Assays
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer Research
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 CNS Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Metabolic Research
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular Research
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Inflammation Research
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Respiratory Research
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Enzo Biochem Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Eurofins DiscoverX Products LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 HD Biosciences Co. Ltd. (WuXi AppTec)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Molecular Devices LLC (Danaher Corporation)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 PerkinElmer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Promega Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis